BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Dexcom Reports Fourth Quarter and Fiscal Year 2018 Financial Results

  The Company also Announces Expansion and Reorganization of its Customer Support Functions

  February 21, 2019

   · 

  13 min read
• Business

  Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2018

  Select Medical Holdings Corporation announced results for its fourth quarter and year ended December 31, 2018.

  February 21, 2019

   · 

  33 min read
• Job Trends

  Advocates Gather in Denver for First Suicide Prevention Day at the Capitol

  Suicide is the tenth leading cause of death in the United States and the seventh leading cause of death in Colorado.

  February 21, 2019

   · 

  3 min read
• Deals

  Covalon Announces Conference Call to Discuss First Quarter Financial Results

  Covalon Technologies Ltd., an advanced medical technologies company, will be releasing its Fiscal 2019 First Quarter financial results on Tuesday February 26th, 2019, after markets close.

  February 21, 2019

   · 

  2 min read
• Business

  Marker Therapeutics Congratulates Helen E. Heslop, MD, DSc (Hon) on Receiving the ASBMT Lifetime Achievement Award

  Marker Therapeutics, Inc. announced that Dr. Helen E. Heslop, Company co-founder and a founding member of Marker’s Scientific Advisory Board, has been recognized with the ASBMT Lifetime Achievement Award at the Transplantation & Cellular Therapy Meetings of ASBMT and CIBMTR 2019.

  February 21, 2019

   · 

  5 min read
• Deals

  Ocular Therapeutix™ Prices $37.5 Million Subordinated Convertible Debt Financing

  Ocular Therapeutix™, Inc. announced that it has entered into a note purchase agreement with an accredited investor to issue $37.5 million aggregate principal amount of 6.00% subordinated convertible notes due 2026 pursuant to Regulation D promulgated under the Securities Act of 1933, as amended.

  February 21, 2019

   · 

  7 min read
• Business

  Alimentation Couche-Tard and Canopy Growth join forces to launch a premium cannabis retail brand in London, Ontario

  Alimentation Couche-Tard Inc. has entered into a multi-year agreement with Canopy Growth Corporation.

  February 21, 2019

   · 

  10 min read
• BioForest

  National Pharmaceutical Council and Discern Health Outline Strategies For Improving Patient-Reported Measures in Oncology

  Comprehensive Study Conducted with Experts from Duke Margolis Center for Health Policy and UNC Lineberger Comprehensive Cancer Center Released

  February 21, 2019

   · 

  4 min read
• Pharm Country

  OncLive® Presents State of the Science Summit™ on Gastrointestinal Malignancies - February 21, 2019

  OncLive® will host its latest State of the Science Summit™ on gastrointestinal malignancies on Tuesday, Feb. 26, from 5 to 9 p.m. at DoubleTree by Hilton Hotel Raleigh-Durham Airport at Research Triangle Park in Durham, North Carolina.

  February 21, 2019

   · 

  2 min read
• Genetown

  Breast Cancer Patients Cut Hot Flashes and Night Sweats by Half with VR-AI Therapy from VRHealth, Report Finds

  Clinical Study Shows That VR Intervention Improves Sleep, Quality of Life

  February 21, 2019

   · 

  3 min read